Influence of the formulation on the maximum tolerated doses of brain targeted nanoparticles of gallic acid by oral administration in Wistar rats

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 12, 2013, Pages 1757-1764

  Nagpal, Kalpana ^a   Singh, Shailendra Kumar ^a   Mishra, Dinanath ^a  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

brain targeting; gallic acid; histopathology; maximum tolerated dose; nanoparticles

Indexed keywords

CHITOSAN; DRUG CARRIER; GALLIC ACID; NANOPARTICLE; POLYSORBATE 80;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BODY WEIGHT; BRAIN; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG DOSE INCREASE; DRUG FORMULATION; DRUG RESPONSE; DRUG TARGETING; HISTOPATHOLOGY; MALE; MAXIMUM TOLERATED DOSE; NONHUMAN; RAT;

BRAIN TARGETING; GALLIC ACID; HISTOPATHOLOGY; MAXIMUM TOLERATED DOSE; NANOPARTICLES;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; BRAIN; CHEMISTRY, PHARMACEUTICAL; GALLIC ACID; MALE; MAXIMUM TOLERATED DOSE; NANOPARTICLES; ORGAN SIZE; RATS; RATS, WISTAR;

EID: 84887944622     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12068     Document Type: Article

References (14)

1. Nagpal K, et al. Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for improved antioxidant and antidepressant-like activity. Drug Deliv 2012; 19: 378-391.
2. Kanno J, et al. Nanomaterial toxicology-importance of chronic toxicity assessment. Toxicol Lett 2010; 196S: S280.
3. Nagpal K, et al. Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull (Tokyo) 2010; 58: 1423-1430.
4. Nagpal K, et al. Formulation, optimization, in vivo pharmacokinetic, behavioral and biochemical estimations of minocycline loaded chitosan nanoparticles for enhanced brain uptake. Chem Pharm Bull (Tokyo) 2013; 61: 258-272.
5. Nagpal K, et al. Evaluation of anti-anxiety activity of nanoparticle mediated delivery of minocycline HCl. Inventi Rapid NDDS 2012; 2012: 1-4.
6. Irwin S,. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiological state of the mouse. Psychopharmacologia (Berl) 1968; 13: 222-257.
7. Rajalakshmi K, et al. Assessment of the no-observed-adverse-effect level (NOAEL) of gallic acid in mice. Food Chem Toxicol 2001; 39: 919-922.
8. Niho N, et al. Subchronic toxicity study of gallic acid by oral administration in F344 rats. Food Chem Toxicol 2001; 39: 1063-1070.
9. Nagpal K, et al. Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB. Expert Opin Drug Deliv 2013; 10: 927-955.
10. Carmona A,. Tannins: thermostable pigments which complex dietary proteins and inhibit digestive enzymes. Arch Latinoam Nutr 1996; 44 (Suppl. 1): 31S-35S.
11. Chung KT, et al. Tannins and human health. Crit Rev Food Sci Nutr 1998; 3: 421-464.
12. Pereverzeva E, et al. Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: focus on cardio- and testicular toxicity. Int J Pharm 2007; 337: 346-356.
13. Zucchi R, Danesi R,. Cardiac toxicity of antineoplastic anthracyclines. Curr Med Chem Anticancer Agents 2003; 3: 151-171.
14. Nerurkar MM, et al. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharm Res 1996; 13: 528-534.